Levebon

Levetiracetam, the active ingredient in Levebon, is an antiepileptic presented as an oral tablet for oral use. It is indicated for the treatment of partial‑onset, generalized tonic‑clonic and myoclonic seizures in patients requiring seizure control.

GNH USA supplies Levebon as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Levetiracetam is used to manage several seizure types by stabilizing neuronal excitability.

Partial‑onset seizures: reduces seizure frequency in focal epilepsy. Generalized tonic‑clonic seizures: helps prevent convulsive episodes. Myoclonic seizures: diminishes rapid, involuntary muscle jerks.

Levetiracetam may cause a range of adverse reactions.

Common Side Effects: - Dizziness - Fatigue - Headache - Irritability - Nausea - Somnolence

Serious or Rare Side Effects: - Severe allergic reactions (e.g., angioedema, anaphylaxis) - Stevens‑Johnson syndrome or toxic epidermal necrolysis - Suicidal thoughts or behavior - Depression or mood changes - Rash or skin eruptions - Blood dyscrasias such as neutropenia

Levetiracetam requires careful monitoring in specific clinical situations.

Renal impairment: adjust dose based on creatinine clearance. Mood changes: monitor for depression, anxiety, or suicidal ideation. Abrupt discontinuation: taper gradually to avoid seizure exacerbation. Hepatic disease: use with caution; monitor liver function. Pregnancy: risk unknown; weigh benefits against potential risks. Store at ambient temperature: keep in original packaging, protect from moisture and direct sunlight.

Levetiracetam can interact with other medicines, influencing efficacy or safety.

Major Interactions (Avoid): - Carbamazepine: may lower levetiracetam plasma concentrations. - Enzyme‑inducing antiepileptics (e.g., phenobarbital, phenytoin): can reduce therapeutic effect. - Strong CYP inhibitors: monitor levels, though effect is limited.

Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, alcohol): may increase sedation. - Hormonal contraceptives: levetiracetam may reduce contraceptive efficacy. - Other antiepileptics: assess for additive side‑effects such as dizziness.